Human Placental Mesenchymal Stem Cells (pMSCs) Play a Role as Immune Suppressive Cells by Shifting Macrophage Differentiation from Inflammatory M1 to Anti-inflammatory M2 Macrophages
Author(s) -
Mohamed Abumaree,
Mohammed Al Jumah,
Bill Kalionis,
Dunia Jawdat,
Abdulaziz Al Khaldi,
Fawaz Abomaray,
Abulhamed Fatani,
Larry Chamley,
B. A. Knawy
Publication year - 2013
Publication title -
stem cell reviews and reports
Language(s) - English
Resource type - Journals
eISSN - 1558-6804
pISSN - 1550-8943
DOI - 10.1007/s12015-013-9455-2
Subject(s) - cd86 , microbiology and biotechnology , biology , cd80 , macrophage , cellular differentiation , mesenchymal stem cell , cd40 , cd14 , immune system , immunology , t cell , cytotoxic t cell , in vitro , biochemistry , gene
Mesenchymal stem cells (MSCs) have a therapeutic potential in tissue repair because of capacity for multipotent differentiation and their ability to modulate the immune response. In this study, we examined the ability of human placental MSCs (pMSCs) to modify the differentiation of human monocytes into macrophages and assessed the influence of pMSCs on important macrophage functions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom